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LETTER TO THE EDITOR
Comparison of Ileofemoral Arterial Access Size Between
Noncontrast 3T MR Angiography and Contrast-Enhanced
Computed Tomographic Angiography in Patients Referred
for Transcatheter Aortic Valve Replacement
Troy M. LaBounty,1,2 Nicole Bhave,1 Shivraman Giri,3
James Balter,2 Antonio Hernandez Conte,4 Ravi Shah,5 and
Venkatesh Murthy1,2
To the Editor:
Severe aortic stenosis is increasingly treated by transcatheter aortic
valve replacement (TAVR). Given the risk of vascular injury,1 accu-
rate measurement of arterial access size—typically by computed
tomography angiography (CTA)—is critical.2 However, renal insuf-
ficiency is common in this population, and CTA contrast may
cause renal injury. We hypothesized that noncontrast 3T magnetic
resonance angiography (MRA) would be an accurate alternative to
CTA to measure ileofemoral arterial size in patients referred for
TAVR. We therefore performed both CTA and noncontrast MRA
in patients with aortic stenosis referred for TAVR, and compared
arterial size and image quality between these tests.
We recruited 12 consecutive adults with aortic stenosis
referred for TAVR with recent contrast-enhanced TAVR-protocol
CTA, after exclusion of two patients unable to lay flat who were
not enrolled. All enrolled patients completed both the CTA and
MRA studies. All patients underwent a clinically indicated TAVR-
protocol CTA. Noncontrast MRA was performed on a 3T scanner
(Magentom Skyra, Siemens, Erlangen, Germany), utilizing a proto-
type quiescent-inflow single-shot (QISS) technique with electrocar-
diogram gating, which relies on magnetization preparation pulses
FIGURE1: Case example. Volume-rendered images of the ileofemoral artery are demonstrated using MRA (A) and CTA (B). Using
a threshold of 7mm, this represents the single case in which MRA (C) reported an adequate minimal diameter (7.1mm) and CTA
(D) did not (6.8mm) in the left femoral artery (arrows). Significant calcium and blooming artifact is present on CTA, which may
explain this difference. Lines and traces on the short-axis images represent the minimal diameter and area, respectively. CTA,
computed tomographic angiography; MRA, magnetic resonance angiography.
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to suppress background signal; after a brief quiescent interval to
allow for inflow of unsuppressed arterial blood, imaging data were
acquired in diastole.3 Slice thickness was 2.1mm, and spatial
resolution was 1.0 3 1.0mm. All studies were completed in <60
minutes.
Studies were interpreted using three blinded readers by con-
sensus. CTA and MRA studies were read in a random sequence,
with at least 2 weeks between interpretations of paired images to
minimize bias. Five arterial segments were evaluated for each
patient (distal aorta, left common iliac, left external iliac/femoral,
right common iliac, and right external iliac/femoral). Measure-
ments were performed using double-oblique short axis views in
each segment, at the site with the smallest diameter. The arterial
mean, minimal, and maximal diameters were measured manually
on these short-axis images (Fig. 1). Image quality was graded on a
Likert scale of 1–4 (1, excellent; 2, good; 3, adequate; 4, nondiag-
nostic). Quantitative image quality was measured using the largest
possible region of interest on short-axis images for each of the five
segments, with the per-patient mean values for signal and noise
compared. The degree of atherosclerosis was characterized as mild,
moderate, or severe for each segment. All studies were interpreted
using OsiriX v. 5.8.1 for Mac OS X (OsiriX Foundation, Geneva,
Switzerland).
Our primary endpoint was a comparison of the mean, mini-
mal, and maximal arterial diameter between CTA and MRA. We
also evaluated intertest agreement for prespecified threshold diame-
ters of 6mm and 7mm, which correspond to minimal sizes for
typical current and recent TAVR devices; as well as comparisons in
graded and quantitative image quality. Analyses were performed
using paired t-tests, Fisher exact tests, Pearson correlations, and
Bland–Altman plots. Statistical analyses were performed using IBM
SPSS v. 22 (Armonk, NY) for Mac OS X. P < 0.05 was consid-
ered significant.
Our Institutional Review Board approved this study, and all
patients provided informed consent for participation. This study is
in accordance with the Declaration of Helsinki.
Mean age was 77.76 10.3 years, and 42% were male. All
studies were completed successfully, and 58/60 arterial segments
were graded good or excellent. Two segments in one patient with
bilateral metallic hip prostheses were graded nonevaluable on both
studies due to artifact and were excluded from analysis. Atheroscle-
rosis was graded as absent, mild, moderate, or severe in 13, 19, 20,
and 6 segments, respectively. All but one patient had atherosclerosis
reported.
There was no mean difference (Fig. 2A–C) in minimal (9.86 3.0
vs. 9.96 3.0mm, P5 0.87), mean (10.56 3.0 vs. 10.56 3.1mm,
FIGURE2: Bland–Altman plots for comparisons of ileofemoral diameters between MRA and CTA. Bland–Altman plots compare the
mean (A), minimal (B), and maximal (C) arterial diameters for each of the 58 arterial segments between CTA and MRA. The
dashed lines demonstrate mean differences (middle) and limits of agreement (61.96 SD). CTA, computed tomographic angiogra-
phy; MRA, magnetic resonance angiography; SD, standard deviation.
P5 0.75), or maximal diameter (11.16 3.2 vs. 11.16 3.0mm,
P5 0.79) between the five segments on CTA and MRA, with excellent
correlation (r5 0.98 for each). For individual segments, there were no
differences between CTA andMRAmeasurements (Table 1). Agreement
within 1mm in mean diameter was observed in 88% (51/58) of seg-
ments, while all segments had agreement within 2mm. Agreement with-
in 1mm in minimal diameter was observed in 90% (52/58) of
segments; all segments had agreement within 2mm. For maximal diam-
eter, agreement within 1mm was seen in 91% (53/58) of segments, and
all segments had agreement within 2mm. The sensitivity and specificity
of MRA (vs. CTA) to identify per-artery (n5 24) minimal diameter
6mm were 100% (21/21) and 100% (3/3); at a threshold of7mm,
the sensitivity and specificity were 93% (14/15) and 89% (8/9). MRA
had lower image signal and noise than CTA, with comparable signal-to-
noise ratio and higher mean image quality grade (Table 1).
A complete pre-TAVR evaluation also requires assessment of
the aorta, aortic valve, and annulus. Our study was limited to
assessment of the ileofemoral artery and distal aorta to determine
the feasibility of noncontrast MRA in this region. A comprehensive
noncontrast assessment could be done using our approach com-
bined with other methods reported accurate for assessment of the
aorta, aortic root, and annulus, such as other noncontrast MRA
techniques4,5 or 3D transesophageal echocardiography.6
We examined a cohort with a high prevalence of atheroscle-
rosis. While MRA does not typically visualize calcification, has
lower spatial resolution, and only imaged the lumen (using our
protocol), we observed good accuracy between tests. One advantage
of MRA is the lack of calcium blooming artifact, but the lack of
calcium visualization may mean that additional testing such as
noncontrast CTmay be needed.
TABLE 1. Comparison of Image Quality and Arterial Diameter Between CTA and MRA
CTA MRA P
Distal aorta
Mean diameter (mm) 15.06 1.8 15.26 1.9 0.51
Minimum diameter (mm) 14.16 2.2 14.16 2.2 0.91
Maximal diameter (mm) 16.16 1.9 15.96 1.7 0.09
Right common iliac artery
Mean diameter (mm) 10.56 1.6 10.66 1.8 0.79
Minimum diameter (mm) 9.76 1.8 9.96 2.1 0.44
Maximal diameter (mm) 10.76 1.7 10.96 1.6 0.34
Right femoral artery
Mean diameter (mm) 8.46 1.3 8.46 1.3 1.0
Minimum diameter (mm) 8.06 1.5 7.86 1.5 0.32
Maximal diameter (mm) 8.76 1.2 8.86 1.2 0.48
Left common iliac artery
Mean diameter (mm) 10.36 1.8 10.56 1.9 0.43
Minimum diameter (mm) 9.66 2.3 9.86 2.2 0.43
Maximal diameter (mm) 11.16 1.8 10.96 1.6 0.45
Left femoral artery
Mean diameter (mm) 8.06 1.4 8.06 1.5 0.76
Minimum diameter (mm) 7.46 1.5 7.66 1.7 0.44
Maximal diameter (mm) 8.56 1.7 8.66 1.6 0.89
Image quality
Signal 393.66 166.0 202.36 47.1 <0.001
Noise 83.36 78.2 43.36 19.4 <0.001
Signal to noise ratio 6.86 5.4 6.56 6.3 0.62
Likert Scale 3.36 0.6 3.86 0.4 0.04
CTA, computed tomographic angiography; MRA, magnetic resonance angiography.
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This study is limited by its small sample size, and larger
studies are needed. MRA also may be limited in patients with prior
ileofemoral stents, and some patients who are referred for TAVR
may have contraindications to MRA such as the inability to lay
flat due to heart failure.
This study demonstrates that noncontrast MRA may be able
to accurately measure ileofemoral arterial access in patients referred
for TAVR, and may represent an alternative to CTA in patients with
chronic renal insufficiency. Future larger studies are needed to better
assess the accuracy of this approach in a larger patient population.
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